ArticleFrontiers in immunology2022
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 31 citations in OpenAlex.
- PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Host Immune Response Mechanisms Against Herpes Simplex Virus Type 2 Infection.Pathogens (Basel, Switzerland) · 2026Review
- Genital herpes shedding episodes associate with altered spatial organization and activation of mucosal immune cells.JCI insight · 2026Article
- Tissue-resident memory T cells reshapeFrontiers in immunology · 2026Review
- Role of mucosal chemokines in the development of tissue-resident CD4Frontiers in immunology · 2026Review
- Distal and local mucosal immunization with a BoHV-4-based vector delivering CpHV-1 gD confers protection against intravaginal CpHV-1 challenge in goats.Frontiers in immunology · 2026Article
- NF-κB/OCT-1 Mediated Upregulation of CXCL14 Chemokine Mobilizes Mucosal Effector Memory CD44+CD62L-CD4+ and CD8+ TEM Cells, and NK Cells Associated with Protection Against Genital Herpes.Pathogens & immunity · 2026Article
- Keeping it local: how CD8 TRMs regulate viral and cancer immunity.Frontiers in immunology · 2025Review
- A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion.PLoS pathogens · 2024Article
- Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines.Vaccines · 2024Review
- Local Power: The Role of Tissue-Resident Immunity in Human Genital Herpes Simplex Virus Reactivation.Viruses · 2024Review
- Therapeutic vaccines for herpesviruses.The Journal of clinical investigation · 2024Review
- Summary of the Centers for Disease Control and Prevention/National Institute of Allergy and Infectious Diseases Joint Workshop on Genital Herpes: 3-4 November 2022.Open forum infectious diseases · 2024Review
- Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia.Journal of neuroinflammation · 2023Article
- Article
- (Not) Home alone: Antigen presenting cell - T Cell communication in barrier tissues.Frontiers in immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
David M KoelleDepartment of Medicine, University of Washington, Seattle, WA, United States.
Lichun DongDepartment of Medicine, University of Washington, Seattle, WA, United States.
Lichen JingDepartment of Medicine, University of Washington, Seattle, WA, United States.
Kerry J LaingDepartment of Medicine, University of Washington, Seattle, WA, United States.
Jia ZhuDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Lei JinDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Stacy SelkeDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Anna WaldDepartment of Medicine, University of Washington, Seattle, WA, United States.
Dana VaronDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Meei-Li HuangDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Christine JohnstonDepartment of Medicine, University of Washington, Seattle, WA, United States.
Lawrence CoreyDepartment of Medicine, University of Washington, Seattle, WA, United States.
Christine M PosavadDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
University of Washington · USFred Hutch Cancer Center · US
Funding
Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4MLarge Scale T Cell Epitope Discovery: Local and Systemic T cell Response to Herpes Simplex Virus75N93019C00063 · NIAID · UNIVERSITY OF WASHINGTON · PI MYER, TIM · 2019 to 2023
$5.5MHarnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus InfectionsR01AI134878 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE · 2018 to 2022
$3.4MModeling of human HSV infection: development of immune-competent 3D skin-on-chip with vascular perfusionR01AI143773 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, JIA · 2020 to 2024
$2.7MCYTOTOXIC T CELL RESPONSES TO HSV IN HIV INFECTIONR01AI042528 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE, ZHU, JIA · 1998 to 2016
$2.7MT Cell Immunity to HSV-2 in Immune Seronegative SubjectsR01AI091701 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI POSAVAD, CHRISTINE M · 2011 to 2015
$1.9MInnate Resistance to Mucosal HSV Infection in HumansR21AI083418 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI POSAVAD, CHRISTINE M · 2009 to 2010
$415kNCI NIH HHS P30 CA015704NIAID NIH HHS 75N93019C00063NIAID NIH HHS R01 AI042528NIAID NIH HHS R01 AI091701NIAID NIH HHS R01 AI134878NIAID NIH HHS R01 AI143773NIAID NIH HHS R21 AI083418
Abstract
Antigen-specific T
Indexed as
Herpes GenitalisHerpes SimplexAntigens, ViralFemaleHerpesvirus 2, HumanHumansImmunologic MemoryMemory T CellsPeptidesAntigens, ViralPeptidesCD4CD8dendritic cellepitopefemale reproductive tract immunologyHSV-2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.